Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMS-D002 in Uterine Fibroids with Menorrhagia
NCT07402369Phase 2Recruiting
- Sponsor
- Shenzhen Kangzhe Biotechnology
- Start
- Feb 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CMS-D002 in Uterine Fibroids (UF), Menorrhagia, sponsored by Shenzhen Kangzhe Biotechnology. Started Feb 2026; status: recruiting.
02
Drugs
CMS-D002
03
Conditions
Uterine Fibroids (UF)Menorrhagia
Beyond the preview
Go deeper on NCT07402369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07402369.